Evidence map›Paper›PMID 40510848›Full record

ArticleHemaSphere2025

Expanding the phenotypic and genetic landscape of congenital neutropenia through whole-exome and genome sequencing.

Séverine Marti, Philippe Pellet, Blandine Beaupain, Léa Durix, Julien Buratti, Yves Réguerre, Nathalie Aladjidi, Saba Azarnoush, Severine Clauin, Wahid Abou Chahla and 23 more

Abstract read
In one paragraph

Article in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Séverine MartiDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne University Paris France.
Philippe PelletDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne University Paris France.
Blandine BeaupainFrench Registry of Chronic Neutropenia Trousseau Hospital Paris France.
Léa DurixINSERM UMR1287, Gustave Roussy Paris-Saclay University Villejuif France.
Julien BurattiDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne University Paris France.
Yves RéguerreDepartment of Pediatric Oncology and Hematology Centre Hospitalo-Universitaire (CHU) de Saint Denis La Réunion France.
Nathalie AladjidiDepartment of Pediatric Oncology and Hematology CHU Bordeaux Bordeaux France.
Saba AzarnoushDepartment of Pediatric Hematology and Immunology Robert Debré Hospital, AP-HP Paris France.
Severine ClauinDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne University Paris France.
Wahid Abou ChahlaDepartment of Pediatric Hematology CHU Lille Lille France.
Gilles BlaisonDepartment of Internal Medicine Louis Pasteur Hospital Colmar France.
Jeremy BertandLaboratoire SeqOIA (FMG2025) Paris France.
Damien BodetDepartment of Pediatric Hematology and Oncology CHU de Caen Caen France.
Benoit BrethonDepartment of Pediatric Hematology and Immunology Robert Debré Hospital, AP-HP Paris France.
Jessica Chane-TengSorbonne University, INSERM UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP Paris France.
Manon DelafoyFrench Registry of Chronic Neutropenia Trousseau Hospital Paris France.
Chrystelle DuprazDepartment of Pediatric Hematology and Oncology CHU Poitiers Poitiers France.
Virginie GandemerDepartment of Pediatric Hematology and Oncology CHU Hôpital Sud Rennes France.
Philippe DenizeauDepartment of Medical Genetics CHU Rennes Rennes France.
Alice GoldenbergDepartment of Medical Genetics CHU Rouen Rouen France.
Pierre HirschDepartment of Biological Hematology, Saint-Antoine Hospital, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, SIRIC CURAMUS Sorbonne University Paris France.
Anaïs l'HaridonLaboratoire SeqOIA (FMG2025) Paris France.
Aude Marie-CardineDepartment of Pediatric Hematology and Oncology Rouen University Hospital Rouen France.
Gabriella VeraDepartment of Medical Genetics CHU Rouen Rouen France.ORCID https://orcid.org/0000-0001-8352-5563
Brigitte NelkenDepartment of Pediatric Hematology CHU Lille Lille France.
Laure NizeryPediatric Department Delafontaine Hospital Saint-Denis France.
Marie NollaDepartment of Pediatric Hematology and Oncology CHU Toulouse Toulouse France.
Marlène PasquetDepartment of Pediatric Hematology and Oncology CHU Toulouse Toulouse France.
Jérémie RosainCentre d'étude des Déficits Immunitaires, Necker Hospital, AP-HP Paris France.
Louis TerriouDepartment of Internal Medicine and Hematology CHU Lille Lille France.
Isabelle PloINSERM UMR1287, Gustave Roussy Paris-Saclay University Villejuif France.ORCID https://orcid.org/0000-0002-5915-6910
Jean DonadieuFrench Registry of Chronic Neutropenia Trousseau Hospital Paris France.ORCID https://orcid.org/0000-0002-4485-146X
Christine Bellanné-ChantelotDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne University Paris France.ORCID https://orcid.org/0000-0001-8415-6771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital neutropenia (CN) comprises a heterogeneous group of rare genetic disorders. While some CN cases present only with neutropenia, others present with additional extra-hematological manifestations. The most common cause of CN is variants in

Identifiers

PMID40510848
PMCPMC12159251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.